FDA approves Zyrtec OTC
Executive Summary
The agency approves allergy treatment Zyrtec (cetirizine) for nonprescription use, one week after it granted Johnson & Johnson approval to switch the decongestant combination product, Zyrtec-D. The prescription-strength product will be available OTC in stores starting in late January 2008, J&J says in a Nov. 16 release...